| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.09 |